We also found that inhibition of PDGFR or PKCα activity efficiently killed BRCA1-deficient human breast cancer cells and that expression of BRCA1 was inversely related to that of PDGFRβ and PKCα in human breast cancer samples. Here, PDGFRB is linked to breast carcinoma.